Nardil (Parke-Davis Div of Pfizer Inc)
Welcome to the PulseAid listing for the Nardil drug offered from Parke-Davis Div of Pfizer Inc. This Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Parke-Davis Div of Pfizer Inc |
| NON-PROPRIETARY NAME: | Phenelzine Sulfate |
| SUBSTANCE NAME: | PHENELZINE SULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Monoamine Oxidase Inhibitor [EPC],Monoamine Oxidase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1961-06-09 |
| END MARKETING DATE: | 0000-00-00 |
Nardil HUMAN PRESCRIPTION DRUG Details:
| Item Description | Nardil from Parke-Davis Div of Pfizer Inc |
| LABELER NAME: | Parke-Davis Div of Pfizer Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 15(mg/1) |
| START MARKETING DATE: | 1961-06-09 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0071-0350_0cee2696-2d79-4e66-919f-10563f612c0c |
| PRODUCT NDC: | 0071-0350 |
| APPLICATION NUMBER: | NDA011909 |
Other PHENELZINE SULFATE Pharmaceutical Manufacturers / Labelers:
